与安非他命相关的幻觉药物在隔离的人类心房中的相反收缩效应
Joachim Neumann1, Britt Hofmann2, Ulrich Gergs1
1Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany.
International journal of molecular sciences
|August 29, 2024
概括
这项研究发现,一些安非他胺衍生物,如DOI和DOM,降低心肌收缩,而美非德龙增加了它. 这些发现凸显了安非他胺衍生物对心脏的多种影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 神经科学是一个神经科学.
背景情况:
- 幻觉性安非他胺具有复杂的生理效应.
- 了解它们对心脏功能的影响至关重要.
研究的目的:
- 为了研究2,5-dimethoxy-4-iodoamphetamine (DOI),2,5-dimethoxy-4-methylamphetamine (DOM) 和mephedrone对人类心房收缩力的影响.
- 为了将这些效应与安非他胺已知的作用进行比较.
主要方法:
- 在电刺激的人类心房准备剂中测量异度收缩力.
- DOI,DOM和美龙的度依赖的应用.
- 评估使用和不使用异上腺素,上腺素,上腺素和可卡因的影响.
主要成果:
- DOI和DOM显著降低了依赖度的方式的收缩力.
- 梅弗德龙增加了收缩力度和时间依赖.
- 梅非德龙的作用被普拉诺洛尔和可卡因减弱,这表明上腺素释放.
结论:
- 胺衍生物可以对心脏收缩力产生相反的影响.
- DOI和DOM表现出负面的内效应,机制不明.
- 梅菲德龙的积极无otropic 效应很可能是由心脏的诺拉丁上腺素释放的介导.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
CNS Stimulants: Psychedelic Agents
132
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
132
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K


